Cargando…

All-trans retinoic acid 45 mg/m(2) is superior to 25 mg/m(2) as the first induction regimen for the treatment of acute promyelocytic leukaemia: a retrospective analysis in a real-world clinical setting

Detalles Bibliográficos
Autores principales:	Zhang, Xinhui, Feng, Shanglong, Xu, Jin, Zhao, Na, Hu, Xing, Zhou, Li, Tong, Juan, Xue, Lei, Zhang, Lei, Han, Yongsheng, Wang, Xingbing, Geng, Liangquan, Zhu, Xiaoyu, Tang, Baolin, Liu, Huilan, Zhu, Weibo, Cai, Xiaoyan, Liu, Xin, Sun, Zimin, Zheng, Changcheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846739/ https://www.ncbi.nlm.nih.gov/pubmed/33514684 http://dx.doi.org/10.1038/s41408-021-00411-9

Ejemplares similares

A comparative study of idarubicin 12 mg/m(2) and 8 mg/m(2) combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients
por: Zhou, Li, et al.
Publicado: (2016)

Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study
por: Wang, Li, et al.
Publicado: (2022)

Impact Of ELN Risk Stratification, Induction Chemotherapy Regimens And Hematopoietic Stem Cell Transplantation On Outcomes In Hyperleukocytic Acute Myeloid Leukemia With Initial White Blood Cell Count More Than 100 × 10(9)/L
por: Feng, Shanglong, et al.
Publicado: (2019)

Transplants of unrelated cord blood or sibling allogeneic peripheral blood stem cells/bone marrow in adolescent and young adults with chronic myeloid leukemia: comparable outcomes but better chronic GVHD-free and relapse-free survival among survivors with cord blood
por: Zheng, Changcheng, et al.
Publicado: (2017)

Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study
por: Sun, Zimin, et al.
Publicado: (2018)

Anti-PML-RARα shRNA sensitises promyelocytic leukaemia cells to all-trans retinoic acid
por: Casey, Nicholas P, et al.
Publicado: (2012)

Thrombocytosis in a male patient with acute promyelocytic leukaemia during all-trans retinoic (ATRA) acid treatment
por: Aldapt, Mahmood B., et al.
Publicado: (2018)

Sequential activation of M1 and M2 phenotypes in macrophages by Mg degradation from Ti-Mg alloy for enhanced osteogenesis
por: Liang, Luxin, et al.
Publicado: (2022)

Two cases of differentiation syndrome with ocular manifestations in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and arsenic trioxide
por: Newman, A.R., et al.
Publicado: (2018)

Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease
por: Zhou, Li, et al.
Publicado: (2019)

Retinoic Acid and Arsenic for Treating Acute Promyelocytic Leukemia
por: Zhou, Guang-Biao, et al.
Publicado: (2005)

A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide
por: Chen, Xue, et al.
Publicado: (2019)

The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK
por: Viljoen, Adie, et al.
Publicado: (2022)

M.G. Krein’s Lectures on Entire Operators
por: Gorbachuk, M L, et al.
Publicado: (1997)

All-trans-retinoic acid–induced pseudotumor cerebri in acute promyelocytic leukemia
por: Anoop, T. M., et al.
Publicado: (2014)

Recent advances in acute promyelocytic leukaemia
por: Ng, Chin-Hin, et al.
Publicado: (2017)

Severe Wernicke encephalopathy and acute pancreatitis due to all-trans-retinoic acid and arsenic trioxide during treatment of acute promyelocytic leukaemia: a case report
por: Jiang, Yan, et al.
Publicado: (2020)

Surface Modification of Biomedical MgCa(4.5) and MgCa(4.5)Gd(0.5) Alloys by Micro-Arc Oxidation
por: Sakiewicz, Piotr, et al.
Publicado: (2021)

All-Trans Retinoic Acid Fosters the Multifarious U87MG Cell Line as a Model of Glioblastoma
por: Pokorná, Markéta, et al.
Publicado: (2021)

SCROTAL ULCERATION FOLLOWING ALL-TRANS RETINOIC ACID THERAPY FOR ACUTE PROMYELOCYTIC LEUKEMIA
por: Tazi, Illias, et al.
Publicado: (2011)

Sweet’s syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid
por: Park, Chi Jun, et al.
Publicado: (2001)

All-trans-retinoic-acid and arsenic trioxide induced remission in promyelocytic blast crisis
por: Colvin, Teresa A., et al.
Publicado: (2018)

2-Bromopalmitate targets retinoic acid receptor alpha and overcomes all-trans retinoic acid resistance of acute promyelocytic leukemia
por: Lu, Ying, et al.
Publicado: (2019)

An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression
por: Lingvay, Ildiko, et al.
Publicado: (2021)

Cytomegalovirus-Specific T Cells from Third-Party Donors Successfully Treated Refractory Cytomegalovirus Retinitis after Unrelated Umbilical Cord Blood Transplantation
por: Li, Na, et al.
Publicado: (2022)

An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg
por: Pratley, Richard E., et al.
Publicado: (2021)

Treating Relapsed/Refractory Acute Myeloid Leukemia with Chidamide, Fludarabine, Cytarabine and Granulocyte-Colony Stimulating Factor with Subsequent Bridging to Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation
por: Yao, Wen, et al.
Publicado: (2022)

Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia
por: Ma, Ya-Fang, et al.
Publicado: (2022)

Diffuse Pulmonary Alveolar Hemorrhage Secondary to All-Trans-Retinoic Acid in Acute Promyelocytic Leukemia
por: Yang, Chen-Lu, et al.
Publicado: (2018)

Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells
por: Misra, Sougat, et al.
Publicado: (2016)

All-Trans Retinoic Acid-Induced Ototoxicity during Chemotherapy in Pediatric Acute Promyelocytic Leukemia
por: Lee, Jong Hyeon, et al.
Publicado: (2021)

Arsenic and all-trans retinoic acid for acute promyelocytic leukemia: yes, it really is as good as it seems
por: Levis, Mark
Publicado: (2021)

Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50‐mg Film‐Coated Tablet
por: Otoul, Christian, et al.
Publicado: (2016)

Ocular Tolerability of Bimatoprost 0.1 mg/mL Preservative-Free versus Bimatoprost 0.1 mg/mL with Benzalkonium Chloride or Bimatoprost 0.3 mg/mL Preservative-Free in Patients with Primary Open-Angle Glaucoma
por: Filippelli, Mariaelena, et al.
Publicado: (2022)

ZYH005, a novel DNA intercalator, overcomes all-trans retinoic acid resistance in acute promyelocytic leukemia
por: Tong, Qingyi, et al.
Publicado: (2018)

Oral Realgar-Indigo Naturalis Formula Plus Retinoic Acid for Acute Promyelocytic Leukemia
por: Lou, Yinjun, et al.
Publicado: (2021)

Mg or Zn for Ca substitution improves the sintering of bioglass 45S5
por: Wetzel, R., et al.
Publicado: (2020)

In vitro and in vivo degradation behavior of Mg–2Sr–Ca and Mg–2Sr–Zn alloys
por: Chen, Kai, et al.
Publicado: (2020)

Role of the promyelocytic leukaemia protein in cell death regulation
por: Salomoni, P, et al.
Publicado: (2012)

Acute Promyelocytic Leukemia: an Experience on 95 Greek Patients Treated in the All-Trans-Retinoic Acid Era
por: Pagoni, Maria, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_u2j2a4v7lfn6hg7j51ai51ite5